Correlations of Bmi-1 expression and telomerase activity in ovarian cancer tissues

Experimental Oncology

Volumn 30, Issue 1, 2008, Pages 70-74

  Zhang, F ^a   Sui, L ^a   Xin, Tao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Bmi 1 expression; Ovarian cancer; Telomerase activity

Indexed keywords

BMI1 PROTEIN; TELOMERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; EPITHELIUM; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PROTEIN EXPRESSION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TELOMERASE; UP-REGULATION;

EID: 42049105538     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Van-lohuizen M, Frasch M, Wientjens E, et al. Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z) 2. Nature 1991; 353: 353-5.
2. Jacobs J J, Kieboom K, Marino S, et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink-4a locus. Nature 1999; 397: 164-8.
3. Mihara K, Chowdhury M, Nakaju N, et al. Bmi-1 is useful as a novel molecular marker for predicting of myelodysplastic syndrome and patient prognosis. Blood 2006; 107: 305-8.
4. Km J H, Yoon S Y, Km C N, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 2004; 203: 217-24.
5. Silva J, Garcia JM, Pena C, et al. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas. Clin Cancer Res 2006; 12: 6929-36.
6. Nowak K, Kerl K, Fehr D, et al. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res 2006; 34: 1745-54.
7. Cui H, Hu B, Li T, et al. Gunning, and Han-Fei Ding. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 2007; 170: 1370-8.
8. Gerider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrehymena extracts. Cell 1985; 43: 405-13.
9. Tahara H, Yasui W, Tahara E, et al. Immunohistochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 1999; 18: 1561-7.
10. Saito M, Handa K, Kiyono T, et al. Immortalization of cementoblast progenitor cells with Bmi-1 and hTERT. Bone Miner Res 2005; 20: 50-7.
11. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
12. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001; 105: 425-31.
13. Park L-K, Qian D, Kiel M, et al. Bmi-1 is required for main-tenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302-5.
14. Molosky AV, Pardal R, Iwashita T, et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425: 962-7.
15. Liu L, Andrews LG, Tollefsbol TO. Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death. Oncogene 2006; 25: 4370-5.
16. Jacobs JJ, Scheijen B, Voncken JW, et al. Bmi-1 collaborates with c-myc in tumorigenesis by inhibiting c-mycinduced apoptosia via INK4a/ARE Genes Dev 1999; 13: 2678-90.
17. Ma Y, Cui W, Yang J, et al. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood 2006; 108: 2726-35.
18. Haupt Y, Alexander WS, Barri G, et al. Novel zinc fingergene implicated as myc collaboratorby retrovirally accelerated lymphomagenesis in Eμ-myctransgenic mice. Cell 1991; 65: 753-63.
19. Guo WJ, Datta S, Band V, Dimri GP. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 2007; 18: 536-46.
20. Dimri GP, Martinez JL, Jacobs JJ, et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 2002; 62: 4735-6.
21. Song LB, Zeng MS, Liao WT, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006; 66: 6225-32.
22. Datar RH, Naritoku WY, Li P, et al. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors and invasive carcinomas. Gynecol Oncol 1999; 74: 338-45.
23. Park TW, Riethdorf S, Riethdorf L, et al. Differenrial telomerase activity expression of the telomerase catalytic subunit and telomerase-RNA in ovarian tumors. Int J Cancer 1999 ; 84: 426-31.
24. Takeda Y, Mori T, Imabayashi H, et al. Can the life span of human marrow stromal cells be prolonged by Bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation. J Gene Med 2004; 6: 833-45.
25. Dimri GP, Martinez JL, Jacobs JJ, et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 2002; 62: 4736-45.
26. Ball AJ, Levine F. Telomere-independent cellular senescence in human fetal cardiomyocytes. Aging Cell 2005; 4: 21-30.
27. Itahana K, Zou Y, Itahana Y, et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 2003; 23: 389-401.